From MASK-air® and SILAM to CATALYSE (Climate Action to Advance HeaLthY Societies in Europe).

Catalyse Climate change MASK-air Pollen SILAM

Journal

Journal of investigational allergology & clinical immunology
ISSN: 1018-9068
Titre abrégé: J Investig Allergol Clin Immunol
Pays: Spain
ID NLM: 9107858

Informations de publication

Date de publication:
26 Jul 2023
Historique:
medline: 27 7 2023
pubmed: 27 7 2023
entrez: 27 7 2023
Statut: aheadofprint

Résumé

Plant species vary under different climate conditions and the distribution of pollen in the air and their trends can be used to assess the impact of climate change on public health. In 2015, MASK-air® (Mobile Airways Sentinel networK for rhinitis and asthma) was launched as a project of the European Innovation Partnership on Active and Healthy Ageing (EIP-on-AHA, DG Santé and DG CONNECT). This project aimed to develop a warning system to inform patients about the pollen season onset. SILAM (System for Integrated modeLling of Atmospheric composition), a global-to-meso-scale dispersion model was developed by the Finnish Meteorological Institute (FMI). It provides quantitative information on atmospheric pollution of anthropogenic and natural origins, particularly on allergenic pollens. POLLAR (Impact of Air Pollution on Asthma and Rhinitis, EIT Health) has combined MASK-air clinical data with SILAM forecasts. A new Horizon Europe grant, CATALYSE (Climate Action to Advance HeaLthY Societies in Europe; grant agreement number 101057131), which started in September 2022, aims at better understanding climate change and finding ways to counteract it. One objectives of this project is to develop early warning systems and predictive models to improve the effectiveness of adaptation strategies to climate change. One of warning system is focused on allergic rhinitis (CATALYSE Task 3.2). with a collaboration between the FMI (Finland), Porto University (Portugal), MASK-air SAS (France), ISGlobal (Spain), Hertie School (Germany) and the University of Zurich (Switzerland). It is to be implemented with the support of EAACI. This paper reports the planning of CATALYSE Task 3.2.

Identifiants

pubmed: 37498647
doi: 10.18176/jiaci.0923
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

0

Auteurs

B Sousa-Pinto (B)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
The first two authors contributed equally to the paper.

Y Palamarchuk (Y)

Finnish Meteorological Institute (FMI), Helsinki, Finland.
The first two authors contributed equally to the paper.

L Leemann (L)

Department of Political Science, University of Zürich, Zurich, Switerland.

S Jankin (S)

Data Science Lab, Hertie School, Berlin, Germany.

X Basagaña (X)

ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

J Ballester (J)

ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.

A Bedbrook (A)

MASK-air SAS, Montpellier, France.

W Czarlewski (W)

MASK-air SAS, Montpellier, France.

R Almeida (R)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.

T Haahtela (T)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

H Haveri (H)

Health and Hospital Care Services, Wellbeing services county of Päijät-Häme, Lahti, Finland.

M Prass (M)

Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Lahti, Finland.
Coordination Unit, Lahti University Campus, Lahti, Finland.

T Henriques (T)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.

R J Vieira (RJ)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.

L Klimek (L)

Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Germany.
Center for Rhinology and Allergology, Wiesbaden, Germany.

M Ollert (M)

Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark.

M H Shamji (MH)

National Heart and Lung Institute, Imperial College, London, UK.
NIHR Imperial Biomedical Research Centre, London, UK.

M Jutel (M)

Department of Clinical Immunology, Wrocław Medical University, Wroclaw, Poland.
ALL-MED Medical Research Institute, Wroclaw, Poland.

S Del Giacco (S)

Department of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital "Duilio Casula", University of Cagliari, Cagliari, Italy.

M J Torres (MJ)

Allergy Unit, Regional University Hospital of Malaga, Malaga University, ARADyAL, Malaga, Spain.

T Zuberbier (T)

Allergy Unit, Regional University Hospital of Malaga, Malaga University, ARADyAL, Malaga, Spain.
Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

J A Fonseca (JA)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
The last four authors contributed equally to the paper.

M Sofiev (M)

Finnish Meteorological Institute (FMI), Helsinki, Finland.
The last four authors contributed equally to the paper.

J M Anto (JM)

ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
The last four authors contributed equally to the paper.

J Bousquet (J)

MASK-air SAS, Montpellier, France.
Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
University Hospital Montpellier, Montpellier, France.
The last four authors contributed equally to the paper.

Classifications MeSH